Ask-CHF
This is a Phase 2 adaptive, double-blinded, placebo-controlled, randomized, multi-center trial study to evaluate the safety and efficacy of a single dose of AB-1002, administered via antegrade intracoronary artery infusion, in males and females age鈥�
- Investigator
- Mustafa M Ahmed
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Rocket RP-NI-A501-0223 (Danon NHS)
The goal of this international observational study is to learn about the natural history of Danon disease in male patients >8 years of age and female patients
- Investigator
- Mustafa M Ahmed
- Status
- Accepting Candidates
- Ages
- 8 Years - N/A
- Sexes
- All
The AX-OUT VAD Bleed Pilot Study
- Investigator
- Mustafa M Ahmed
- Status
- Accepting Candidates
